Inmed to present at the emerging growth conference

Vancouver, british columbia--(newsfile corp. - june 10, 2024) - inmed pharmaceuticals inc. (nasdaq: inm) ("inmed" or the "company"), a clinical stage pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates, today announced the company will be presenting at the upcoming emerging growth conference scheduled for june 12-13, 2024. inmed's ceo, mr.
INM Ratings Summary
INM Quant Ranking